The COVID-19 Pandemic and Post-Infection Irritable Bowel Syndrome: What Lies Ahead for Gastroenterologists
Clin Gastroenterol Hepatol
.
2022 Oct;20(10):2195-2197.
doi: 10.1016/j.cgh.2022.05.044.
Epub 2022 Aug 6.
Authors
Walter W Chan
1
,
Madhusudan Grover
2
Affiliations
1
Division of Gastroenterology, Hepatology and Endoscopy, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
2
Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota. Electronic address: Grover.Madhusudan@mayo.edu.
PMID:
35944588
PMCID:
PMC9356717
DOI:
10.1016/j.cgh.2022.05.044
No abstract available
Publication types
Research Support, N.I.H., Extramural
MeSH terms
COVID-19*
Gastroenterologists*
Humans
Irritable Bowel Syndrome* / complications
Irritable Bowel Syndrome* / epidemiology
Pandemics
Grants and funding
R01 DK127998/DK/NIDDK NIH HHS/United States